The Activist Hedge Fund Effect

How these hedge funds are pulling companies away from basic scientific work

Scientist on one side and men in suits on the other

This is a summary of a story that originally appeared on Fuqua School of Business.

A new study from Duke University’s Fuqua School of Business and the University of Utah finds that activist hedge funds are changing how America’s most research‑intensive companies innovate, often pulling them away from the kind of basic scientific work that results in breakthroughs.

These hedge funds buy a meaningful stake in a company to push management for changes that increase shareholder value.

Elia Ferracuti and Rahul Vashishtha of Duke, along with Kevin Standbridge of Utah, found that after activists intervene, companies cut back their output of academic publications. Within five years, scientific publications fall by 20 to 30 percent, with the steepest declines in high‑impact journals. The researchers analyzed 639 hedge‑fund‑led activist campaigns over two decades. They focused on 487 firms known for producing scientific research.

The shift doesn’t mean companies stop innovating, say the researchers. Patent activity remains steady, but the nature of innovation changes. Firms move away from basic science and toward applied, incremental inventions that are more predictable and more likely to deliver short‑term financial gains.

The pharmaceutical sector best illustrates this trend. After activist pressure, applications for original drug compounds drop by 31 percent, while spin-off versions of existing treatments jump by 133 percent. These drugs can be profitable, but they rarely result in new therapeutic frontiers.

“It’s a reorientation away from the discovery of new scientific knowledge and toward the application of existing scientific knowledge,” Ferracuti said.

While the researchers acknowledge that activism can improve efficiency and boost innovation, they warn that companies dependent on long‑term science need strong, informed shareholders and committed boards to protect their research. Without that support, they argue that foundational discoveries that result in future breakthroughs could continue to erode.

For more information, go to the Fuqua School of Business.